BRIDGEBIO PHARMA INC - NOTE 2.250% 2/0

Historical Holders from Q1 2022 to Q1 2025

CUSIP: 10806XAD4
Type / Class: Debt / NOTE 2.250% 2/0
All holders as of December 31, 2024: Q4 2024
Principal, excl. options: 628M
Holdings value: $539M
% of all portfolios: 0.001%
Grand Portfolio weight change: 0%
Number of holders: 38
Number of buys: 20
Number of sells: -11
Average Value change %: +0%
Average buys %: +0%
Average sells %: 0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of BRIDGEBIO PHARMA INC - NOTE 2.250% 2/0

Period	Principal	Value	Change	Price	Investors
2025 Q1	$21K	$1.89M	+$576K	$90.06	1
2024 Q4	$628M	$539M	-$2.45M	$0.86	38
2024 Q3	$632M	$532M	-$6.33M	$0.84	38
2024 Q2	$642M	$515M	-$50.2M	$0.80	42
2024 Q1	$698M	$605M	-$20.6B	$0.82	41
2023 Q4	$639M	$549M	+$29.4M	$0.85	39
2023 Q3	$616M	$493M	+$44M	$0.75	44
2023 Q2	$503M	$337M	+$7.89M	$0.62	40
2023 Q1	$516M	$356M	-$7.13B	$0.64	43
2022 Q4	$544M	$510M	-$1.15M	$0.39	35
2022 Q3	$499M	$547M	-$37.6M	$0.44	33
2022 Q2	$595M	$249M	-$26M	$0.41	34
2022 Q1	$625M	$307M	+$298M	$0.48	36